Lumanity
@lumanity.bsky.social
We revolutionize how value is generated, demonstrated, and communicated to unlock the full potential of your brand and your company
We had a blast celebrating the end of the year and holiday season with colleagues in Boston earlier this week.
We wish everyone a peaceful and bright end of 2025!
We wish everyone a peaceful and bright end of 2025!
December 19, 2025 at 7:01 PM
We had a blast celebrating the end of the year and holiday season with colleagues in Boston earlier this week.
We wish everyone a peaceful and bright end of 2025!
We wish everyone a peaceful and bright end of 2025!
From shifting #FDA priorities to complexities of #RareAndOrphan #DrugDevelopment, 2025 has been full of challenges — and opportunities. Explore actionable insights to navigate #Regulatory uncertainty, reduce risk, and maximize value in your programs: buff.ly/HyhctET
December 16, 2025 at 12:01 PM
From shifting #FDA priorities to complexities of #RareAndOrphan #DrugDevelopment, 2025 has been full of challenges — and opportunities. Explore actionable insights to navigate #Regulatory uncertainty, reduce risk, and maximize value in your programs: buff.ly/HyhctET
Generating #RWE in #SpinalMuscularAtrophy (#SMA) faces hurdles with evolving standard of care, inconsistent outcomes measurement, severity baseline, and the need for long-term follow-up. Test your objectives with us: buff.ly/Qj6Z6Uq
#HCRU #SpinalCare #RealWorldEvidence
#HCRU #SpinalCare #RealWorldEvidence
December 15, 2025 at 8:00 AM
Generating #RWE in #SpinalMuscularAtrophy (#SMA) faces hurdles with evolving standard of care, inconsistent outcomes measurement, severity baseline, and the need for long-term follow-up. Test your objectives with us: buff.ly/Qj6Z6Uq
#HCRU #SpinalCare #RealWorldEvidence
#HCRU #SpinalCare #RealWorldEvidence
In a crowded healthcare market, simply having data is no longer enough. Tune into the podcast to learn how to transform information into insights and insights into real competitive advantage! buff.ly/htwkckB
#LaunchReadiness #CompetitiveIntelligence #ClinicalData #LaunchExcellence #ClinicalInsights
#LaunchReadiness #CompetitiveIntelligence #ClinicalData #LaunchExcellence #ClinicalInsights
December 11, 2025 at 4:04 PM
In a crowded healthcare market, simply having data is no longer enough. Tune into the podcast to learn how to transform information into insights and insights into real competitive advantage! buff.ly/htwkckB
#LaunchReadiness #CompetitiveIntelligence #ClinicalData #LaunchExcellence #ClinicalInsights
#LaunchReadiness #CompetitiveIntelligence #ClinicalData #LaunchExcellence #ClinicalInsights
The PHARMO Institute, part of Lumanity, conducts collaborative post-licensure studies on vaccine benefits, safety, and coverage, utilizing our unique, longitudinal, and clinically rich dataset. Learn more about our expertise in our factsheet: buff.ly/dgkZX2z
December 11, 2025 at 8:01 AM
The PHARMO Institute, part of Lumanity, conducts collaborative post-licensure studies on vaccine benefits, safety, and coverage, utilizing our unique, longitudinal, and clinically rich dataset. Learn more about our expertise in our factsheet: buff.ly/dgkZX2z
Season's greetings from Lumanity!
We wish you and your loved ones a peaceful, bright, and joyous season.
We wish you and your loved ones a peaceful, bright, and joyous season.
December 10, 2025 at 4:01 PM
Season's greetings from Lumanity!
We wish you and your loved ones a peaceful, bright, and joyous season.
We wish you and your loved ones a peaceful, bright, and joyous season.
The Pharmacy Benefits Revolution isn’t just for big players. The secret? Knowing what to adopt, what to avoid, and how to keep your people at the center of every decision. Learn how mid-size organizations are leveling the playing field: buff.ly/UhBojm7
#MarketAccess #PBM #DrugPricing
#MarketAccess #PBM #DrugPricing
December 9, 2025 at 4:03 PM
The Pharmacy Benefits Revolution isn’t just for big players. The secret? Knowing what to adopt, what to avoid, and how to keep your people at the center of every decision. Learn how mid-size organizations are leveling the playing field: buff.ly/UhBojm7
#MarketAccess #PBM #DrugPricing
#MarketAccess #PBM #DrugPricing
It's not too late to register for tomorrow's webinar! Explore how #EarlyAssetStrategy decisions have an outsized impact on long-term success, anticipated market and #regulatory shifts, and how embedding #PatientInsights can set the stage for sustained success event.on24.com/wcc/r/514567...
December 8, 2025 at 4:03 PM
It's not too late to register for tomorrow's webinar! Explore how #EarlyAssetStrategy decisions have an outsized impact on long-term success, anticipated market and #regulatory shifts, and how embedding #PatientInsights can set the stage for sustained success event.on24.com/wcc/r/514567...
In the latest episode of our #MedicalAffairs Unscripted podcast, we address why the Target Product Profile (TPP) is the true foundation of modern #DrugDevelopment.
Listen: buff.ly/1nzN3YV
#MedicalAffairsUnscripted #TargetProductProfile #TPP #MedAffairs #CMO
Listen: buff.ly/1nzN3YV
#MedicalAffairsUnscripted #TargetProductProfile #TPP #MedAffairs #CMO
December 5, 2025 at 12:01 PM
In the latest episode of our #MedicalAffairs Unscripted podcast, we address why the Target Product Profile (TPP) is the true foundation of modern #DrugDevelopment.
Listen: buff.ly/1nzN3YV
#MedicalAffairsUnscripted #TargetProductProfile #TPP #MedAffairs #CMO
Listen: buff.ly/1nzN3YV
#MedicalAffairsUnscripted #TargetProductProfile #TPP #MedAffairs #CMO
Many in the Netherlands celebrate #Sinterklaas on December 5. Sinterklaas is a holiday where creativity plays a key role and is all about bringing people together and creating a warm, festive atmosphere. Yesterday our Utrecht celebrated with second hand gifts and a dice game!
#FijneSinterklaas
#FijneSinterklaas
December 5, 2025 at 8:00 AM
Many in the Netherlands celebrate #Sinterklaas on December 5. Sinterklaas is a holiday where creativity plays a key role and is all about bringing people together and creating a warm, festive atmosphere. Yesterday our Utrecht celebrated with second hand gifts and a dice game!
#FijneSinterklaas
#FijneSinterklaas
If you're planning to be at this week's American Society of #Hematology (#ASH) Annual Meeting & Exposition? We would love to connect and explore the latest research and scientific breakthroughs with you there!
Email [email protected] to schedule time to meet with our experts.
Email [email protected] to schedule time to meet with our experts.
December 4, 2025 at 4:16 PM
If you're planning to be at this week's American Society of #Hematology (#ASH) Annual Meeting & Exposition? We would love to connect and explore the latest research and scientific breakthroughs with you there!
Email [email protected] to schedule time to meet with our experts.
Email [email protected] to schedule time to meet with our experts.
In the #Netherlands, nearly 1.2 million people are estimated to have #diabetes, and in 2019, the cost of diabetes care was €1.3 billion. Check out the #retrospective, #observational cohort study at buff.ly/mSfkk3P
#TD2 #Type2Diabetes #RWE #Semaglutide
#TD2 #Type2Diabetes #RWE #Semaglutide
December 3, 2025 at 8:00 AM
In the #Netherlands, nearly 1.2 million people are estimated to have #diabetes, and in 2019, the cost of diabetes care was €1.3 billion. Check out the #retrospective, #observational cohort study at buff.ly/mSfkk3P
#TD2 #Type2Diabetes #RWE #Semaglutide
#TD2 #Type2Diabetes #RWE #Semaglutide
Our new whitepaper explores what falling drug prices and renewed FDA scrutiny of promotional activities mean for the industry and how a strong clinical outcome assessment (COA) strategy can expand patient reach, improve adherence, and keep communications compliant.
lumanity.com/perspectives...
lumanity.com/perspectives...
December 2, 2025 at 4:02 PM
Our new whitepaper explores what falling drug prices and renewed FDA scrutiny of promotional activities mean for the industry and how a strong clinical outcome assessment (COA) strategy can expand patient reach, improve adherence, and keep communications compliant.
lumanity.com/perspectives...
lumanity.com/perspectives...
Interactions with the U.S. #FDA represent some of the most pivotal moments in the product development lifecycle. Access key strategies to ensure your organization makes the most of every #FDA interaction: buff.ly/9zkotWO
#DrugDevelopment #RegulatoryStrategy #ClinicalDevelopment #RegulatoryAffairs
#DrugDevelopment #RegulatoryStrategy #ClinicalDevelopment #RegulatoryAffairs
December 1, 2025 at 8:02 PM
Interactions with the U.S. #FDA represent some of the most pivotal moments in the product development lifecycle. Access key strategies to ensure your organization makes the most of every #FDA interaction: buff.ly/9zkotWO
#DrugDevelopment #RegulatoryStrategy #ClinicalDevelopment #RegulatoryAffairs
#DrugDevelopment #RegulatoryStrategy #ClinicalDevelopment #RegulatoryAffairs
Join us to explore how early-stage decisions have an outsized impact on long-term success, anticipated market and regulatory shifts, and how embedding #PatientInsights can set the stage for sustained success. Register: event.on24.com/wcc/r/514567...
#PatientInsights #EarlyAssetStrategy
#PatientInsights #EarlyAssetStrategy
December 1, 2025 at 12:01 PM
Join us to explore how early-stage decisions have an outsized impact on long-term success, anticipated market and regulatory shifts, and how embedding #PatientInsights can set the stage for sustained success. Register: event.on24.com/wcc/r/514567...
#PatientInsights #EarlyAssetStrategy
#PatientInsights #EarlyAssetStrategy
Wishing you a peaceful and festive Thanksgiving holiday!
We are thankful for our staff and clients who share our focus on improving patients’ lives. Their passion and collaboration drive our work. Together, we are building a healthier world.
We are thankful for our staff and clients who share our focus on improving patients’ lives. Their passion and collaboration drive our work. Together, we are building a healthier world.
November 27, 2025 at 12:00 PM
Wishing you a peaceful and festive Thanksgiving holiday!
We are thankful for our staff and clients who share our focus on improving patients’ lives. Their passion and collaboration drive our work. Together, we are building a healthier world.
We are thankful for our staff and clients who share our focus on improving patients’ lives. Their passion and collaboration drive our work. Together, we are building a healthier world.
ISPOR Europe 2025 gave us a panoramic view of a rapidly evolving #HealthTechnology landscape. From value-based healthcare models to #PatientCenteredOutcomes, the shift is global.
Read about these trends and what they mean for market access strategies: buff.ly/3FgYcsa
#ISPOREurope #HEOR #HTA
Read about these trends and what they mean for market access strategies: buff.ly/3FgYcsa
#ISPOREurope #HEOR #HTA
Our experts share key takeaways from ISPOR Europe 2025
Lumanity experts reflect on the discussions at ISPOR Europe which centered around the global impact of the EU’s JCA, US healthcare policy, and Gen AI
buff.ly
November 27, 2025 at 8:00 AM
ISPOR Europe 2025 gave us a panoramic view of a rapidly evolving #HealthTechnology landscape. From value-based healthcare models to #PatientCenteredOutcomes, the shift is global.
Read about these trends and what they mean for market access strategies: buff.ly/3FgYcsa
#ISPOREurope #HEOR #HTA
Read about these trends and what they mean for market access strategies: buff.ly/3FgYcsa
#ISPOREurope #HEOR #HTA
ICYMI, we opened up a dialogue last week with industry experts surrounding the challenges and potential changes to Direct-to-Consumer (#DTC) advertising in the US. Watch: event.on24.com/wcc/r/512150...
#BrandComms #PatientAdvocacy #DTCAds #FDA #HealthcareMarketing #Pharma #Biotech
#BrandComms #PatientAdvocacy #DTCAds #FDA #HealthcareMarketing #Pharma #Biotech
November 26, 2025 at 4:01 PM
ICYMI, we opened up a dialogue last week with industry experts surrounding the challenges and potential changes to Direct-to-Consumer (#DTC) advertising in the US. Watch: event.on24.com/wcc/r/512150...
#BrandComms #PatientAdvocacy #DTCAds #FDA #HealthcareMarketing #Pharma #Biotech
#BrandComms #PatientAdvocacy #DTCAds #FDA #HealthcareMarketing #Pharma #Biotech
We’re looking forward to next week's #PHLEXSummit! Will you be in attendance? If so, reach out to [email protected] to schedule time to meet with us on-site. For more info on the summit: buff.ly/wld2kKE
#LaunchExcellence #CommercialStrategy #PharmaLandscape #PHLEX
#LaunchExcellence #CommercialStrategy #PharmaLandscape #PHLEX
November 26, 2025 at 8:00 AM
We’re looking forward to next week's #PHLEXSummit! Will you be in attendance? If so, reach out to [email protected] to schedule time to meet with us on-site. For more info on the summit: buff.ly/wld2kKE
#LaunchExcellence #CommercialStrategy #PharmaLandscape #PHLEX
#LaunchExcellence #CommercialStrategy #PharmaLandscape #PHLEX
ICYMI, last week we brought experts together to explore the future of #ImmunoOncology, from highlights of #SITC2025, to addressing modalities, #PatientQOL, regulatory changes, and trends for 2026. Watch: buff.ly/Yd8TXXL
#CancerTherapy #Biologics #Biotech #DrugDevelopment
#CancerTherapy #Biologics #Biotech #DrugDevelopment
November 25, 2025 at 8:01 PM
ICYMI, last week we brought experts together to explore the future of #ImmunoOncology, from highlights of #SITC2025, to addressing modalities, #PatientQOL, regulatory changes, and trends for 2026. Watch: buff.ly/Yd8TXXL
#CancerTherapy #Biologics #Biotech #DrugDevelopment
#CancerTherapy #Biologics #Biotech #DrugDevelopment
Indication prioritization is a complex, high‑stakes decision that isn’t just another checklist item in #DrugDevelopment; it is the strategic decision that defines the trajectory of an entire program. Read: buff.ly/cSECH0t
#Regulatory #CommercialSuccess #Pharma #Biotech
#Regulatory #CommercialSuccess #Pharma #Biotech
November 25, 2025 at 4:18 PM
Indication prioritization is a complex, high‑stakes decision that isn’t just another checklist item in #DrugDevelopment; it is the strategic decision that defines the trajectory of an entire program. Read: buff.ly/cSECH0t
#Regulatory #CommercialSuccess #Pharma #Biotech
#Regulatory #CommercialSuccess #Pharma #Biotech
A new study in Primary Care Diabetes provided the first longitudinal analysis of routine primary care data on #T2D monitoring, treatment targets, and medication prescribing in migrants compared to non-migrants in the #Netherlands. Read with #OpenAccess: buff.ly/lBjYpAr
November 20, 2025 at 8:00 AM
A new study in Primary Care Diabetes provided the first longitudinal analysis of routine primary care data on #T2D monitoring, treatment targets, and medication prescribing in migrants compared to non-migrants in the #Netherlands. Read with #OpenAccess: buff.ly/lBjYpAr
In our latest whitepaper, we share our views on the recommendations of the EMA and what this means for manufacturers bringing new products to market in the European Union.
Download our paper today lumanity.com/perspectives...
#LumanityPerspectives #PCO
#PatientCentric #PED #EMA
Download our paper today lumanity.com/perspectives...
#LumanityPerspectives #PCO
#PatientCentric #PED #EMA
November 19, 2025 at 8:00 PM
In our latest whitepaper, we share our views on the recommendations of the EMA and what this means for manufacturers bringing new products to market in the European Union.
Download our paper today lumanity.com/perspectives...
#LumanityPerspectives #PCO
#PatientCentric #PED #EMA
Download our paper today lumanity.com/perspectives...
#LumanityPerspectives #PCO
#PatientCentric #PED #EMA
Exciting news! Lumanity was recognized with a Public Service Announcements Award of Excellence by the #RXClub for our campaign supporting CancerCare’s Pet Assistance & Wellness Program. Thank you @CancerCare for partnering with us. Learn more: lumanity.com/lumanity-nam...
#HealthcareMarketing
#HealthcareMarketing
November 17, 2025 at 8:00 PM
Exciting news! Lumanity was recognized with a Public Service Announcements Award of Excellence by the #RXClub for our campaign supporting CancerCare’s Pet Assistance & Wellness Program. Thank you @CancerCare for partnering with us. Learn more: lumanity.com/lumanity-nam...
#HealthcareMarketing
#HealthcareMarketing
Our latest whitepaper explores the growing need for #EvidenceTransportability, use cases, challenges in applying non-local data, and our framework to effectively assess and enable it buff.ly/LCS7MjB
#RWE #HTA #JCA #StakeholderEngagement #DataValidation
#RWE #HTA #JCA #StakeholderEngagement #DataValidation
Evidence Transportability in HTA & JCA Decision-Making
Explore the need for evidence transportability, common use cases, challenges, and learn about our structured evidence transportability framework. Read now.
buff.ly
November 17, 2025 at 12:01 PM
Our latest whitepaper explores the growing need for #EvidenceTransportability, use cases, challenges in applying non-local data, and our framework to effectively assess and enable it buff.ly/LCS7MjB
#RWE #HTA #JCA #StakeholderEngagement #DataValidation
#RWE #HTA #JCA #StakeholderEngagement #DataValidation